-
Forward Look
The Right MatchNew NCI clinical trial will link patients to drugs that target their tumors.
by Whitney L.J. Howell
-
Forward Look
Childhood Cancer Survivors at Risk for Hormone DeficienciesNew study highlights importance of survivorship care.
by Sharon Reynolds
-
Forward Look
Identifying Ovarian Cancer RiskStudy may help spotlight women who would benefit from risk reduction strategies.
by Carrie Printz
-
First Person
To Test or Not to TestTwenty-two years after the first of two breast cancer diagnoses, a survivor decides to undergo genetic testing.
by Cynthia Ryan
-
Breaking the Blood-Brain Barrier
Advances in treating brain metastases and reducing their side effects are bringing new hope to cancer patients.
by Sue Rochman
-
Colorectal Cancer: A Troubling Trend
More people are being diagnosed with colorectal cancer before 50, the recommended age to start screening.
by Charlotte Huff
-
Healthy Habits
Pile on the VeggiesA study evaluates whether a change in diet could slow prostate cancer growth.
by Melinda Mahaffey Icden
-
Healthy Habits
Nothing Healthy About a TanThe CDC calls for community efforts to halt rising rates of melanoma.
by Brenda Conaway
-
The DCIS Dilemma
Ductal carcinoma in situ is the fourth most common cancer diagnosis in women. Some say it's not "really" cancer. But you wouldn't know that based on how it is treated.
by Sue Rochman
-
Healthy Habits
Reaping the BenefitsFollowing a vegetarian diet could reduce your risk of colorectal cancer.
by Leigh Labrie
Cancer Talk
Many People Don’t Get Colonoscopy After Receiving Abnormal Blood Tests
About half of people who receive abnormal results from colorectal cancer screening tests don’t follow up with a colonoscopy.
by Laura Gesualdi Gilmore
Can Steroids Impair Immunotherapy for Cancer?A new study suggests steroids could blunt the effects of some immunotherapies, but researchers say they remain necessary for some patients.
by Kyle Bagenstose
Treatment Combination Improves Survival in Platinum-resistant Ovarian CancerPreliminary results found that combining relacorilant with nab-paclitaxel improved outcomes for women with advanced ovarian cancer.
by Sandra Gordon
CAR T-cell Therapy Shows Response in Rare Brain CancerPotential new approach to treating diffuse intrinsic pontine glioma uses engineered immune cells infused directly to the brain.
by Taneia Surles
